Patients with SLE or APS are more susceptible to atherosclerotic cardiovascular events; immunological alterations, such as antibodies to oxidized LDL, aPLs, and antibodies to B2GPI, may have implications for premature atherosclerosis in SLE and APS.15 Here, APOH is linked to systemic lupus erythematosus.